Author:
Kubanova A. A.,Kubanov A. A.,Karamova A. E.,Proshutinskaya D. V.
Abstract
Atopic dermatitis is a chronic recurrent inflammatory disease caused, inter alia, by violations of the barrier function of the skin and pathological immune response in the form of an imbalance of Th1 and Th2 lymphocytes with increased production of IL-4, IL-5, IL-13, IL-31. Treatment of severe forms of atopic dermatitis is not an easy task due to the variability of the individual response to treatment, the short duration of the therapeutic effect and the frequent development of undesirable phenomena associated with the use of existing methods of systemic immunosuppressive therapy. The study of the pathogenesis of atopic dermatitis made it possible to identify the spectrum of molecular targets, providing the basis for researching alternative variants to the previously used systemic therapy methods – genetic engineering biological preparations. Contemporary data on the pathogenesis of atopic dermatitis as well as potential molecular targets for innovative biological preparations, the efficacy of which has been evaluated through clinical trials, are presented in the review.
Publisher
Rossijskoe Obschestvo Dermatovenerologov i Kosmetologov
Reference132 articles.
1. Самсонов В. А., Знаменская Л. Ф., Резайкина С. Ю. и др. Патогенетические подходы к лечению атопического дерматита. Materia Medica. 2000;(1):50–59. [Samsonov V. A., Znamenskaya L. F., Rezajkina S. Yu. i dr. Patogeneticheskie podhody k lecheniyu atopicheskogo dermatita. MateriaMedica. 2000;(1):50–59.]
2. Кубанова А. А., Прошутинская Д. В., Текучева Л. В., Авдиенко И. Н. Интегральный подход к наружной терапии атопического дерматита. Вестник дерматологии и венерологии. 2010;(1):20–26. [Kubanova A. A., Proshutinskaya D. V., Tekucheva L. V., Avdienko I. N. Integral approach to the external therapy of atopic dermatitis.Vestnik dermatologii i venerologii. 2010;(1):20–26.]
3. Аксенова О. И., Марченко В. Н., Монахов К. Н. Состояние вегетативной нервной регуляции у больных атопическим дерматитом. Вестник современной клинической медицины. 2014;7(4):15–17. [Aksenova O. I., Marchenko V. N., Monahov K. N. Sostoyanie vegetativnoj nervnoj regulyacii u bol’nyh atopicheskim dermatitom. Vestnik sovremennoj klinicheskoj mediciny. 2014;7(4):15–17.]
4. Мельников В. Л., Рыбалкин С. Б., Митрофанова Н. Н., Агейкин А. В. Некоторые клинико-эпидемиологические аспекты течения атопического дерматита на территории Пензенской области. Фундаментальные исследования. 2014;(10-5):936–940. [Mel’nikov V. L., Rybalkin S. B., Mitrofanova N. N., Agejkin A. V. Nekotorye kliniko-ehpidemiologicheskie aspekty techeniya atopicheskogo dermatita na territorii Penzenskoj oblasti. Fundamental’nye issledovaniya. 2014;(10-5):936–940.]
5. Bissonnette R., Papp K. A., Poulin Y., et al. Topical tofacitinib for atopic dermatitis: a phase IIa randomized trial. Br J Dermatol. 2016;175(5):902–911.
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献